에 대한 최신 뉴스 US Foods Hldg (NYSE:USFD) 주식

US Foods Hldg

Tyme Technologies

US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.

Analyst Color

Equities

News

Price Target

Reiteration

Markets

Analyst Ratings

Trading Ideas

General

DAPP

TMUS

USFD

BofA 증권의 애널리스트 제이슨 쿠퍼버그(Jason Kupferberg)는 블록(NYSE:XYZ)에 대해 매수 등급을 재확인하며 목표 주가를 115달러로 제시했다. 이 애널리스트는 블록을 2025년 최고의 결제 서비스 선택지로 강조하며, 유리한 거시경제 환경과 스퀘어(Square) GPV의 성장 덕분에 아웃퍼폼할 가능성이 있다고 전했다.

블록이 S&amp;P 500에 편입? BofA 분석가는 회사가 모든 기준을 충족한다고 주장

신선한 양파와 관련된 대장균(E. coli) 발생에 대응하여, 주요 미국 패스트푸드 체인인 맥도날드(NYSE:MCD), 레스토랑 브랜드 인터내셔널(NYSE:QSR) 그리고 얌 브랜즈(NYSE:YUM)가 메뉴에서 해당 채소를 제거하기로 결정했다. 이 사건으로 인해 49명이 병을 앓았고 한 명이 사망한 것으로 전해졌다.

쿼터 파운더 대장균 공포 속에 맥도날드의 라이벌 버거킹, 얌 브랜즈가 메뉴에서 양파 제거

Earnings

Long Ideas

Pre-Market Outlook

TRAK

VRAR

미국 주식 선물이 월요일 아침(현지 시간 기준)에 하락 거래되고 있는 가운데, 오늘 투자자들의 주목을 받을 수 있는 주식들은 다음과 같다: 1. 월스트리트는 카니발(NYSE:CCL)이 월요일 개장 전 매출 78억 3천만 달러, 주당 1.16달러의 분기 이익을 보고할 것으로 예상하고 있다. 카니발의 주가는 시간외 거래에서 1% 상승한 18.72달러를 기록했다.

월요일 주목해야 할 주식: 카니발, US 푸즈, 리포시트랙 그리고 2종목

US Foods Holding Corp

Plug Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are trading lower premarket on Tuesday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44096388/plug-power-announces-continued-cash-flow-improvement-and-progress-on-path-to-profitability" rel="noreferrer noopener">reported fourth-quarter&nbsp;results</a>.
The company reported&nbsp;revenue of&nbsp;$191.5 million, missing <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">analyst&nbsp;estimates&nbsp;of&nbsp;$263.2 million</a>.
The company reached a pivotal milestone in electrolyzer deployments, expanded its hydrogen network, and enhanced the utilization of its manufacturing facilities.
Electrolyzer revenue escalated 583% Y/Y, aided by 5-MW system sales and a large-scale order deployment.
Customer warrant charges stood at $22.7 million, impacted by updated forecasts and the timing of customer programs.
In the fourth quarter, operating cash flow improved 46% year over year (Y/Y), led by margin expansion and better working capital efficiency.
Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/technicals/25/03/44088446/plug-power-stock-nears-oversold-territory-will-q4-earnings-be-the-turning-point" rel="noreferrer noopener">Plug Power Stock Nears Oversold Territory: Will Q4 Earnings Be The Turning Point?</a>
In the quarter, the company reported a gross margin loss of 122%, reflecting a strategic deceleration in investments for mobility, high-power stationary applications, and product development.
Despite the significant improvement in cash burn, the company said it determined that the strategic actions to temper the investment pace on certain platforms, coupled with the fact that certain markets are developing slower than expected, collectively resulted in accounting conclusions to record varied non-cash impairments of certain long-lived and intangible assets.
The company recorded $971.3 million in non-cash charges for asset impairments and bad debt provisions in the fourth quarter on strategic shifts and market demand pushouts.
These impairments are expected to lower future depreciation and amortization by an estimated <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$55 million – $60 million in 2025</a>.
Plug CEO Andy Marsh said, &#8221;While we made great strides in improving cash flows in 2024, it is clear based on market dynamics that we have to make additional strides, therefore we are initiating Project Quantum Leap to further position Plug for success in the near and long term by continuing to leverage the platforms we have built while further optimizing the Company.&#8221;
Plug Power expects Project Quantum Leap to reduce annual expenses in the range of $150 million to $200 million.
These measures are expected to include additional reductions in the workforce over the coming weeks, furthering its rooftop facility consolidations, additional reductions in discretionary spending, additional reduction and leveraging of inventory, and limiting capital expenditures to near-term critical requirements.
The company expects that taking these actions will further improve margins and cash flows and accelerate the path to profitability.&nbsp;
As of 2024, unrestricted cash stood at over $200 million. The company expects cash burn in 2025 to continue to significantly improve.
Investors can gain exposure to the stock via&nbsp;ProShares S&amp;P&nbsp;Kensho Cleantech ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTEX#NYSE">CTEX</a>).&nbsp;
Price Action: PLUG shares are down 2.00% at $1.47 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44042800/plug-power-ties-executive-compensation-plan-to-stock-performance" target="_blank" rel="noreferrer noopener">Plug Power&#8217;s High-Stakes Move: Executives Can Take Up To 75% Of Pay In Company Stock</a></li>
</ul>
Photo via Shutterstock.

Guidance

Small Cap

Movers

CTEX

PLUG

Plug Power Tightens Its Belt: Plans Massive Cost Cuts & Cash Burn Control In New Strategy

Citigroup analyst Joanne Wuensch upgrades Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) from Neutral to Buy and raises the price target from $92 to $107.

Upgrades

Citigroup Upgrades Medtronic to Buy, Raises Price Target to $107

On Monday, March 3rd, U.S. markets closed sharply lower after Trump announced 25% tariffs on Canada and Mexico, with the S&amp;P 500 seeing its worst drop since December. Stocks had already slipped after an ISM survey showed declining manufacturing PMI. Investors, expecting a delay, reacted as markets priced in the tariff impact.
Related: <a target="_blank" href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" rel="noreferrer noopener">Markets Tank After Trump Confirms More Tariffs: Here&#8217;s What Wall Street Is Saying</a>
The New Orders Index contracted to 48.6%, while the Production Index expanded to 50.7%. Prices surged to 62.4% due to tariff-driven costs. Employment fell to 47.6%, indicating workforce reductions. New Export Orders dipped to 51.4%, while Imports rose to 52.6%.
Most S&amp;P 500 sectors fell, led by tech, energy, and consumer discretionary stocks, while real estate and consumer staples gained.
The Dow Jones Industrial Average fell 1.348% to close at 43,191.24, the S&amp;P 500 declined 1.76% to 5,849.72, and the Nasdaq Composite was down 2.64% to 18,350.19.
Asia Markets Today
<ul>
<li>On Tuesday, Japan&#8217;s Nikkei 225 declined 1.34% to 37,318.50, led by losses in the Fishery, Transportation Equipment, and Chemical sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 slid 0.58%, closing at 8,198.10, led by losses in the Energy, Utilities and Resources sectors.</li>
<li>India&#8217;s Nifty 50 was down 0.18% to 22,080.30, led by losses in the Auto, Technology, and Fast-Moving Consumer Goods sectors, while the Nifty 500 gained 0.06% to 19,909.40.</li>
<li>China&#8217;s Shanghai Composite gained 0.22% to 3,324.21, and the Shanghai Shenzhen CSI 300 fell 0.08% to 3,885.22.</li>
<li>Hong Kong&#8217;s Hang Seng fell 0.28%, ending the session at 22,941.77.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was down 1.85%.</li>
<li>Germany&#8217;s DAX declined 1.98%.</li>
<li>France&#8217;s CAC fell 1.14%.</li>
<li>U.K.&#8217;s FTSE 100 index traded lower by 0.29%</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.80% at $67.82/bbl, and Brent was down 1.10% at $70.82/bbl.</li>
<li>Oil prices fell as OPEC+ confirmed an April output hike, and U.S. tariffs on Canada, Mexico, and China took effect, prompting retaliatory measures. Trump&#8217;s pause on Ukraine aid also raised speculation of potential Russian sanctions relief, further pressuring crude markets.</li>
<li>Natural Gas declined 0.46% to $4.102.</li>
<li>Gold was trading higher by 0.80% at $2,924.29, Silver was up 0.47% to $32.465, and Copper slipped 1.62% to $4.5322.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures were down 0.15%, S&amp;P 500 futures fell 0.16% and Nasdaq 100 futures slid 0.04%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. Dollar Index slipped 0.26% to 106.27, USD/JPY was down 0.43% to 148.85, and USD/AUD rose 0.02% to 1.6069.</li>
<li>The U.S. dollar fell Tuesday amid trade tensions and economic slowdown fears despite new tariffs on Canada, Mexico, and China.</li>
<li>Trump&#8217;s <a href="https://www.benzinga.com/news/25/03/44092335/trumps-tariffs-threaten-canada-mexico-china-and-american-wallets" target="_blank" rel="noreferrer noopener">25% tariffs</a> on Canada and Mexico and increased duties on Chinese goods took effect, triggering retaliatory measures. China imposed new tariffs and restrictions, while Canada and Mexico planned countermeasures. Markets reacted negatively, fearing economic disruptions, rising costs, and recession risks. Trump&#8217;s aggressive trade policies continue reshaping global commerce.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Decline; Oil Falls As OPEC+ Confirms Output Hike - Global Markets Today While US Slept

Amylyx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.52) by 5.77 percent. This is a 885.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $(665.00 thousand) in sales this quarter. This is a 100.61 percent decrease over sales of $108.45 million the same period last year.

Earnings Misses

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

Amylyx Pharma Q4 EPS $(0.55) Misses $(0.52) Estimate

Citigroup analyst Patrick Donnelly downgrades Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) from Buy to Neutral and maintains the price target from $185 to $185.

Downgrades

Citigroup Downgrades Quest Diagnostics to Neutral, Maintains Price Target to $185

U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures of all benchmark indices fell in premarket trading except Nasdaq 100.
Investor anxiety over tariffs loomed as the March 4 deadline for tariff imposition on Mexico and Canada neared. President Donald Trump indicated on Monday that there was &#8220;no room left&#8221; for tariff negotiations with Canada and Mexico. He will be addressing the Congress today, which is expected to give further clarity on tariffs and other policies.
Meanwhile, the Treasury yields slipped further on Tuesday. The 10-year Treasury yield stood at 4.16%, while the two-year yield was at 3.93%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 91% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.03%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.06%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.33%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Tuesday. SPY was up 0.046% to $584.04, and QQQ advanced 0.23% to $498.20, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Real estate, consumer staples, health care and utilities were the only sectors that advanced on Monday. The market witnessed the second worst trading day of March ever as information technology, energy, consumer discretionary, and materials led the decline.
On the economic front, February&#8217;s S&amp;P final U.S. manufacturing PMI came in at 52.7 as compared to the preliminary reading of 51.6. This was at a 32-month high signaling an improvement in the health of the manufacturing sector.
The ISM Manufacturing PMI rose to 50.3 in February 2025, indicating a second consecutive month of slight expansion for U.S. manufacturing. In January, private residential construction spending decreased by 0.4%, with notable reductions in both multifamily construction and home improvement expenditures.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.64%</td>
<td>18,350.19</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.76%</td>
<td>5,849.72</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.48%</td>
<td>43,191.24 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.81%</td>
<td>2,102.24</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Bearish investor sentiment surged to a near-historic 60.6% in late February, the highest in 30 months, signaling a potential contrarian buying opportunity.
Ryan Detrick of Carson Research noted that historically, stocks average a 28% gain a year after such high bearish readings, although exceptions like 2008 exist. He observed that even at a 55% bearish threshold, returns are generally strong.
Detrick suggests that barring a financial crisis, which he deems unlikely, "investors willing to stay strong and not panic sell" could see significant gains, with the S&amp;P 500 averaging nearly 13% higher in six months and 18% in a year following similar sentiment spikes.
Talking about the effects of Trump's policies on the market, the chairman and CIO of Navellier &amp; Associates, Louis Navellier said, "The volatility is certainly being fed by Trump 2.0 moves, with tariffs scheduled to be launched soon,"
Economist Jeremy Siegel, on the other hand, stated that investors are taking profits on high-flying tech and reconsidering value stocks. However, he added that slowing economic growth could hamper the value stocks as well. "In a weakening economy, all stocks face challenges, though dividend-paying and more defensive equities may benefit from lower interest rates," he added.
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep on Tuesday:
<ul>
<li>New York Fed President John Williams will speak at 2:20 p.m. ET, whereas, Richmond Fed President Tom Barkin will speak at an undetermined time.</li>
</ul>
Stocks In Focus:
<ul>
<li>Crowdstrike Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) was up 0.34% in the premarket on Tuesday ahead of its earnings, which will be released after the opening bell. Analysts expect it to report earnings of 86 cents per share on revenue of $1,034.3 million.</li>
</ul>
<ul>
<li>Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) advanced 0.39% as Wall Street expects it to report quarterly earnings of $2.25 per share on revenue of $30.85 billion before the opening bell.</li>
</ul>
<ul>
<li>Green Dot Corporation. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) jumped 15.50% as it surpassed fourth-quarter earnings and revenue expectations and appointed Kim Olson as the new CFO.</li>
</ul>
<ul>
<li>Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) climbed 6.14% as private equity firm Sycamore Partners could take the company private by Thursday this week, reported WSJ.</li>
</ul>
<ul>
<li>Sacks Parente Golf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) slumped 37.16% after it announced a 1-for-30 reverse stock split.</li>
</ul>
<ul>
<li>Tenaya Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNYA#NASDAQ">TNYA</a>) dropped 25.02% as the company announced plans for a public offering of units, including common stock and two warrant series, plus pre-funded units with immediately exercisable warrants.</li>
</ul>
<ul>
<li>Sphere Entertainment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) was 0.16% lower as it missed the earnings estimates.</li>
</ul>
<ul>
<li>Biodesix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) surged 18.65% after reporting a total revenue reaching $71.3 million, up 45% year-on-year.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.11% to hover around $67.61 per barrel.
The gold spot index was up by 0.90% to $2,919.13 per ounce. Its last record high was at $2,956.37 per ounce. The Dollar Index was down 0.46% at the 106.254 level.
Asian markets were lower on Tuesday as India's S&amp;P BSE Sensex, China's CSI 300, South Korea's Kospi, Japan's Nikkei 225, Australia's ASX 200, and Hong Kong's Hang Seng index declined. European markets were also lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants">Mark Cuban Supports Trump&#8217;s New &#8216;Gold Card&#8217; Scheme If Sold To Corporations For Employee Citizenship: Here&#8217;re The Listed-Companies With Most Number Of Immigrants</a></li>
</ul>
Photo courtesy: Shutterstock

Government

Market Summary

Economics

BDSX

CRWD

GDOT

SPGC

SPHR

TNYA

US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert

Citigroup analyst Patrick Donnelly upgrades Charles River (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) from Sell to Neutral and raises the price target from $155 to $175.

Citigroup Upgrades Charles River to Neutral, Raises Price Target to $175

HYMTF

Hyundai Motor And Tate Announce Máret Ánne Sara As Next Hyundai Commission Artist

Tech

RDWR

Radware To Hold Its Hackers Challenge On March 13 In Peru

Citigroup analyst Anthony Pettinari initiates coverage on Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) with a Buy rating and announces Price Target of $19.

Initiation

TTAM

Citigroup Initiates Coverage On Titan America with Buy Rating, Announces Price Target of $19

Health Care

FDA Approves TEVIMBRA In US For The First-Line Treatment Of Adults with Unresectable Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Citigroup analyst Vikram Bagri initiates coverage on Centrus Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LEU#AMEX">LEU</a>) with a Neutral rating and announces Price Target of $104.

Citigroup Initiates Coverage On Centrus Energy with Neutral Rating, Announces Price Target of $104

Biotech

ESPR

Esperion Expects Full Year 2025 Operating Expenses Of $215M-$235M, Including Approximately $15M In Non-cash Expenses Related To Stock Compensation

Modiv Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDV#NYSE">MDV</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.31 by 19.35 percent. This is a 7.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $11.66 million which beat the analyst consensus estimate of $11.39 million by 2.37 percent. This is a 5.09 percent decrease over sales of $12.29 million the same period last year.

Earnings Beats

Modiv Industrial Q4 AFFO $0.37 Beats $0.31 Estimate, Sales $11.66M Beat $11.39M Estimate

Esperion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 78 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $69.11 million which beat the analyst consensus estimate of $61.58 million by 12.22 percent. This is a 114.30 percent increase over sales of $32.25 million the same period last year.

Esperion Therapeutics Q4 2024 GAAP EPS $(0.11) Beats $(0.16) Estimate, Sales $69.11M Beat $61.58M Estimate

On Tuesday, Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) unveiled VeloSky, which is a unified networking solution that enables Communications Service Providers (CSPs) to integrate fiber, cellular, and<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44101257/broadcom-launches-velosky-to-deliver-network-convergence-transform-connectivity" rel="noreferrer noopener"> satellite connectivity into a single appliance</a>.
Designed to enhance the adoption of 5G and satellite services, VeloSky helps providers unlock new revenue opportunities and diversify their business models.
The solution, built on the VeloRAIN (Robust AI Networking) architecture, offers advanced visibility, prioritization, and automation, enabling enterprises to optimize operations and enhance user experiences.
VeloSky unifies wired and wireless networks under a single platform, integrating fiber, 5G fixed wireless, and satellite connectivity without separate hardware.
With zero-touch provisioning, real-time monitoring, and a unified management console, it streamlines operations, reduces costs, and enhances security.
VeloSky ensures seamless, scalable, and reliable connectivity to meet evolving enterprise demands of service providers.
Sanjay Uppal, vice president and general manager, VeloCloud Division, Broadcom, said, &#8220;By unifying diverse network underlays into a single, AI-optimized platform, service providers can deliver premium, differentiated services to enterprise customers while simplifying operations and accelerating time-to-revenue.&#8221;
Last month, the company announced the availability of its end-to-end PCIe Gen 6 portfolio and a partnership with Micron Technology <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/02/43990982/broadcom-shares-are-on-the-rise-today-whats-going-on" rel="noreferrer noopener">for&nbsp;AI infrastructure expansion</a>.
Investors can gain exposure to the stock via Columbia Select Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMI#NYSE">SEMI</a>) and VanEck Fabless Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMHX#NASDAQ">SMHX</a>).
Price Action: AVGO shares are down 0.72% at $186.03 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44088049/berkshire-hathaway-hits-1-07-trillion-market-cap-surpassing-tesla-earnings-shock-and-teslas-decline-highlight-changing-markets" target="_blank" rel="noreferrer noopener">Berkshire Hathaway Hits $1.07 Trillion Market Cap, Surpassing Tesla – Earnings Shock and Tesla&#8217;s Decline Highlight Changing Markets</a></li>
</ul>
Image via Shutterstock.

Large Cap

AVGO

SEMI

SMHX

Broadcom Debuts VeloSky To Accelerate 5G And Satellite Adoption

Barclays analyst Richard Hightower upgrades Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) from Underweight to Equal-Weight and raises the price target from $74 to $75.

Barclays Upgrades Agree Realty to Equal-Weight, Raises Price Target to $75

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/04070131/ZTE-0304-01.jpeg" alt="" class="wp-image-7073" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/04070131/ZTE-0304-01.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/04070131/ZTE-0304-01-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/04070131/ZTE-0304-01-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The telecoms equipment seller's revenue began declining in the second half of last year, and fell 10% in the fourth quarter
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>ZTE's revenue dropped for first time last year since 2018 as its core business slumped with reduced 5G spending by Chinese wireless carriers</li>
<li>The telecoms equipment maker's AI and enterprise businesses show promise, but lower margins and the potential for new U.S. sanctions could pose challenges</li>
</ul>
Crippling U.S. sanctions on&nbsp;ZTE Corp.&nbsp;(0763.HK; 000063.SZ) in 2018 brought the Chinese telecoms giant to the brink of collapse, forcing it to pay a historic $1.4 billion penalty and overhaul its leadership to secure relief. Since then, the company has embarked on a grueling recovery path, pivoting to lower its reliance on U.S. suppliers, strengthen its position in the domestic market, and broaden its product portfolio beyond telecoms equipment.
By 2022, ZTE appeared to turn a corner as its annual revenue finally rebounded to surpass pre-sanctions levels in 2017, signaling a tentative comeback. But the company's&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0228/2025022801495.pdf">latest financial report</a>&nbsp;for 2024 paints a more complex picture. Decelerating revenue growth, compressed profit margins, and persistent tensions between Beijing and Washington are casting shadows over the sustainability of its recovery in an increasingly fractured global technology landscape.
The company's 2024 report, released last Friday, reveals a sobering milestone: ZTE's annual revenue dropped 2.38% year-over-year to 121.3 billion yuan ($16.7 billion), marking its first decline since U.S. sanctions caused its revenue to tumble by 21% in 2018. This reversal ends a five-year recovery streak that peaked at 13% growth in 2021 before decelerating to 7% in 2022 and just 1% in 2023. Meantime, its net income last year also slipped into contraction, falling 9.7%, contrasting with marginal gains in earlier years.
On a quarterly basis, ZTE reported year-on-year revenue gains in the first two quarters of 2024, only to slip into accelerating revenue contraction in the second half of the year. Those declines culminated with a 10% drop in the fourth quarter to 31.3 billion yuan.
The slowdown contrasts sharply with crosstown rival&nbsp;Huawei, which was hit with even harsher U.S. sanctions but has&nbsp;<a href="https://thebambooworks.com/huawei-rings-up-improbable-comeback-as-revenue-soars/">bounced back</a>&nbsp;more strongly by developing alternative non-U.S. suppliers and moving into new areas like intelligent driving. ZTE has made similar efforts, which we'll detail shortly, though the results have been more limited.
Investors weren't too impressed with ZTE's latest report, with its Hong Kong-listed stock tumbling 12.5% the day after the announcement. At its Monday close, the stock is now roughly where it stood just before the original U.S. sanctions in 2018.
ZTE's slowdown coincides with a broader downturn in China's telecommunications sector. After years of aggressive investment in 5G infrastructure, the country's three major state-owned carriers — China Mobile, China Telecom, and China Unicom — collectively cut their capital spending by 5.4% in 2024, the first annual drop since 2018, according to Communication Weekly, a state-affiliated industry publication.
The pullback hit ZTE's core business hard. Revenue from its carrier network segment — which covers telecoms equipment and accounts for over half of its sales — sank 15% year-over-year in 2024. Others reporting&nbsp;<a href="https://thebambooworks.com/comba-telecom-rings-up-red-ink-on-5g-spending-slowdown/">similar difficulties</a>&nbsp;last year include China-focused telecoms software makers&nbsp;Comba&nbsp;(2342.HK) and&nbsp;AsiaInfo&nbsp;(1675.HK; 688225.SH).
<h4 class="wp-block-heading">Diversification effort</h4>
ZTE's geographic revenue mix has shifted dramatically since the U.S. sanctions of 2018. Revenue from U.S. and European markets dropped to 15% of its total in 2024, down from 25% in 2017, according to its latest report.
Despite expectations that ZTE might pivot strongly toward emerging markets friendlier to Chinese investment, progress has been limited. Africa, for example, contributed just 5.3% to overall revenue in 2024, marginally up from 3.5% in 2017. The slow expansion reflects the challenge of competing with Huawei's established dominance in these regions, even as those countries accelerate their build-out of 5G infrastructure.
Instead, ZTE has primarily looked inward and redirected its focus to its home China market, which now accounts for 68% of revenue, up from 57% in 2017. The company's efforts to diversify its product portfolio are also focused on China.
Those efforts are centered on its government and corporate business segment, which includes servers and enterprise software. This segment grew by an impressive 37% last year, accounting for 15.3% of revenue, up from 9% in 2017. The company's consumer electronics, including smartphones and tablets, grew 16%, but its 27% share of revenue remains below its 2017 level of 32%.
In its 2024 report, ZTE emphasizes the growth potential of its government and corporate business, pointing to surging demand for AI servers and software services amid the AI boom. It also highlights government support through policies like "East Data, West Computing," a national initiative to expand data center infrastructure across China. But even in these areas, the company must compete with far more established giants, led by hometown rival&nbsp;Lenovo&nbsp;(0992.HK), as well as foreign rivals like&nbsp;Dell&nbsp;(DELL.US).
Capitalizing on AI opportunities, ZTE moved quickly to tap into the momentum created by DeepSeek, whose recent breakthrough success has sparked nationwide demand for AI infrastructure. Last month, ZTE introduced AiCube, a hardware system that combines AI training and inference functions, aiming to support various computing scenarios and speed up AI deployment for its clients.
However, expanding into this business also presents challenges. The company's government and corporate segment operates on notably thinner margins than the telecoms equipment business, partly due to the high component costs of AI servers and related infrastructure. ZTE's 2024 report reveals the segment's gross profit margin was just 15% last year, significantly lower than the 51% margin for its traditional telecoms equipment business. This margin difference was a key factor in the company's reduced net income for the year.
Beyond operational challenges, investors might also want to weigh geopolitical risks as ZTE expands into these new sectors.
The AI server business illustrates such vulnerabilities, since such systems depend heavily on AI chips from U.S. suppliers like Nvidia or domestic chips made with U.S. technology. Though China can still import certain lower-tier Nvidia chips under current rules, the unpredictable nature of U.S. export controls creates ongoing uncertainty for this business line.
Another pressing concern is the potential for ZTE to fall victim to new U.S. restrictions, given rising tensions with China under the new administration of President Donald Trump. While ZTE's recent supply chain diversification efforts may help avoid a repeat of its 2018 crisis, challenges remain.
Though ZTE has not fully disclosed its mitigation strategies, Chinese media reports indicate the company has increased procurement from domestic chip suppliers. In ZTE's 2024 annual report, Chairman Li Zixue emphasized the company's commitment to developing independent core technologies. This focus is reflected in ZTE's R&amp;D spending, which has doubled from around 10% of revenue pre-sanctions to 20% last year.
In the near term, ZTE's biggest challenge probably lies not in potential sanctions but in navigating the slowdown in China's telecoms equipment spending. With China's 5G networks mostly built and domestic carriers tightening budgets, the company's success will depend on how quickly it can scale up new growth areas like AI infrastructure and enterprise solutions, while expanding its presence in non-Western markets.

ZTE comeback stumbles on China telecoms spending slowdown

Barclays analyst Aman Rakkar upgrades HSBC Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBC#NYSE">HSBC</a>) from Equal-Weight to Overweight.

HSBC

Barclays Upgrades HSBC Holdings to Overweight

DA Davidson analyst Rudy Kessinger upgrades Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) from Neutral to Buy and raises the price target from $90 to $125.

OKTA

DA Davidson Upgrades Okta to Buy, Raises Price Target to $125

Press Releases

US Foods Reports Third Quarter Fiscal Year 2024 Earnings

US Foods Names First National Class of US Foods Scholars to Fuel Culinary Talent Pipeline for Operators

US Foods to Present at the 2024 Morgan Stanley Global Consumer & Retail Conference

US Foods to Present at the 2025 ICR Conference

US Foods Helping Communities Make It Program Contributes Nearly $14.5M in Donations in 2024

US Foods Reaffirms Fiscal Year 2024 Guidance

US Foods to Host Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call and Webcast

US Foods to Webcast Presentation at the CAGNY 2025 Conference

US Foods Reports Fourth Quarter and Fiscal Year 2024 Earnings

US Foods to Present at the 2025 CAGNY Conference

Andersons

The Chefs' Warehouse, Inc. - Common Stock

The Chefs' Warehouse

Davis Commodities Limited - Ordinary Shares

Davis Commodities

HF Foods Group

Performance Food Group Company Common Stock

Performance Food Gr

SpartanNash

Sysco

United Natural Foods

Piper Sandler

Truist Securities

Barclays

Morgan Stanley

BofA 증권의 애널리스트 제이슨 쿠퍼버그(Jason Kupferberg)는 블록(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>)에 대해 매수 등급을 재확인하며 <a href="https://www.benzinga.com/quote/XYZ/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가를 115달러</a>로 제시했다.
이 애널리스트는 블록을 2025년 최고의 결제 서비스 선택지로 강조하며, 유리한 거시경제 환경과 스퀘어(Square) GPV의 성장 덕분에 아웃퍼폼할 가능성이 있다고 전했다.
또한, 이 애널리스트는 이 회사가 40의 법칙(Rule of 40) 목표를 예정보다 일찍 달성하고 S&amp;P 500에 포함될 가능성이 있다고 예상했다.
이 회사의 매출 성장과 수익성의 조합은 대형 결제 서비스 부문에서 강력하게 평가되었다.
이 애널리스트는 스퀘어의 GPV 성장률이 주가 성과에 매우 중요하다고 강조하고, CEO 잭 도시와 영업 책임자 닉 몰나르(Nick Molnar) 하의 새로운 제품 혁신과 전략적 파트너십을 부각했다. 여기에는 통합된 스퀘어 앱, 주문 플랫폼, US 푸즈 홀딩 및 T-모바일 US와의 주요 유통 파트너십이 포함된다.
또한 읽기: <a href="https://www.benzinga.com/general/biotech/25/02/43525518/eli-lilly-q4-earnings-strong-demand-for-mounjaro-but-prices-dip-forecasts-over-30-jump-in-2025-sales-on-newer-medicines" target="_blank" rel="noreferrer noopener">일라이 릴리 4분기 실적: 마운자로에 대한 강한 수요, 가격 하락, 2025년 신약 매출 30% 이상 증가 전망</a>
이 애널리스트는 블록이 2025년 15% 이상의 GP 성장 전망을 유지하고 400bps(베이시스포인트)의 마진 확장을 이룰 것이라고 예측했지만, 최근 주가 상승이 4분기를 긍정적인 촉매제로 작용하는 영향을 제한할 수 있다고 언급했다.
최근 <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>에 따르면, XYZ 주식은 지난 1년 동안 3% 이상 하락했습니다. 투자자는 VanEck Digital Transformation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAPP#NASDAQ">DAPP</a>)를 통해 해당 주식에 투자할 수 있습니다.
가격 동향: XYZ 주식은 목요일 0.12% 상승 86.08달러에 마감되었다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/downgrades/25/02/43506847/spotify-analyst-draws-comparison-to-apple-on-scale-pricing" target="_blank" rel="noreferrer noopener">스포티파이 애널리스트, 규모와 가격 측면에서 애플과 비교</a></li>
</ul>
이미지 제공: Shutterstock.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

블록이 S&P 500에 편입? BofA 분석가는 회사가 모든 기준을 충족한다고 주장

신선한 양파와 관련된 대장균(E. coli) 발생에 대응하여, 주요 미국 패스트푸드 체인인 맥도날드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), 레스토랑 브랜드 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) 그리고 얌 브랜즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>)가 메뉴에서 해당 채소를 제거하기로 결정했다. 이 사건으로 인해 49명이 병을 앓았고 한 명이 사망한 것으로 전해졌다.
무슨 일이 (What Happened): 로이터에 따르면, 버거킹의 모회사인 레스토랑 브랜드 인터내셔널과 얌 브랜즈도 신선한 양파를 메뉴에서 제외하기로 결정했다. 한 대변인은 약 5%의 버거킹 매장이 이미 이 변경을 실시했다고 확인했다.
이 보도에 따르면 콜로라도주 롱몬트 버거킹의 매니저 마리아 곤잘레스(Maria Gonzales)는 &#8220;앞으로 당분간 양파를 전혀 사용하지 말라는 회사 측의 지시를 받았다&#8221;고 말했다.
맥도날드는 오염된 양파의 출처가 테일러 팜스(Taylor Farms)임을 확인했으며 현재 리콜되었다. 미국의 주요 식품 서비스 공급업체인 US 푸즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)의 메모에 따르면 콜로라도 시설의 노란 양파가 회수되었다.
미국 식품의약국(FDA)는 영향을 받은 맥도날드 매장들의 공급업체는 테일러 팜스라고 발표하고 리콜을 시작했다고 전했다. 이 건강 규제 당국은 연방 및 주 당국과 회사들과 협력하여 양파가 발생의 원인인지 확인하고 있다.
왜 중요한가 (Why It Matters): 이번 발생은 맥도날드 햄버거와 연관된 대장균 사례가 최근에 보고된 후 발생한 일로, 이로 인해 이 <a href="https://www.benzinga.com/news/24/10/41494285/mcdonalds-stock-is-tumbling-wednesday-heres-why">회사의 주가가 하락</a>한 바 있다. 미국 질병통제예방센터(CDC)는 10개 주에서 49건의 대장균 감염 사례가 확인되었으며, 대부분의 환자들이 McDonald's의 쿼터 파운더(Quarter Pounder) 햄버거를 먹었다고 보고했다.
FDA는 여러 사람이 맥도날드의 쿼터 파운더와 관련된 대장균으로 아프게 된 후 테일러 팜스에 대한 <a href="https://www.benzinga.com/news/24/10/41527681/fda-launches-investigation-into-mcdonalds-supplier-taylor-farms-following-e-coli-outbreak">조사</a>를 시작했다. FDA는 현재 맥도날드 햄버거에 제공된 슬라이스 양파가 오염의 가장 가능성이 높은 원인이라고 생각하고 있다.
발생에도 불구하고, 애널리스트들은 이전에 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41494741/mcdonalds-well-positioned-to-contain-e-coli-outbreak-analysts-say-impact-minimal-co">맥도날드 주식에 미치는 영향이 미미할 것</a>이라고 언급했다. 그러나 베어드 에퀴티 리서치(Baird Equity Research)의 애널리스트 데이비드 타란티노(David Tarantino)는 소비자 심리에 대한 우려로 수요일 늦게 맥도날드의 주가를 &#8216;중립&#8217;으로 하향 조정했다.
가격 움직임: 목요일, 맥도날드 주식은 정규 거래에서 1% 상승하여 $301.58에 마감되었으며, 이후 시간외 거래에서는 0.12% 추가 상승하였다.
다음 읽을 내용: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41459673/whats-going-on-with-trump-media-technology-stock-today?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">트럼프 미디어 &amp; 기술 주식에 무슨 일이 일어나고 있나요?</a></li>
</ul>
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>에 의해 편집되었습니다.

미국 주식 선물이 월요일 아침(현지 시간 기준)에 하락 거래되고 있는 가운데, 오늘 투자자들의 주목을 받을 수 있는 주식들은 다음과 같다:
1. 월스트리트는 카니발(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>)이 월요일 개장 전 매출 78억 3천만 달러, 주당 1.16달러의 분기 이익을 보고할 것으로 예상하고 있다. 카니발의 주가는 시간외 거래에서 1% 상승한 18.72달러를 기록했다.
2. US 푸즈 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)가 5억 달러의 무담보 선순위 채권 사모 발행 가격을 발표했다. US 푸즈의 주식은 애프터 마켓에서 2.2% 오른 61.49달러로 거래되었다.
3. 애널리스트들은 리포시트랙(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>) 최신 분기에 1주당 6센트의 이익과 507만 달러의 매출을 기록할 것으로 예상하고 있다. 이 회사는 시장이 마감된 후에 실적을 발표할 예정이다. 리포시트랙의 주식은 애프터 마켓에서 0.1% 오른 17.72달러로 거래되었다.
여기에서 <a href="https://www.benzinga.com/premarket/">프리마켓 보도</a>를 확인하십시오.
4. 에스페이 매뉴펙처링 &amp; 일렉트로닉스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESP#NYSE">ESP</a>)는 4분기 주당 73센트의 이익을 기록했으며, 이는 작년 동기 36센트에서 증가한 수치이다. 매출은 834만 달러에서 1,161만 달러로 증가했다. 에스페이의 주식은 애프터 마켓에서 9.6% 상승한 27.20달러로 거래되었다.
5. 애널리스트들은 글림스 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>)가 시장 마감 후에 1주당 8센트의 분기 손실과 200만 달러의 매출을 기록할 것으로 예상하고 있다. 글림스 그룹의 주식은 애프터 마켓에서 3.3% 하락한 0.77달러로 거래되었다.
다음 확인하세요:
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41075978/top-4-materials-stocks-that-may-implode-in-q3">3분기에 폭락할 수 있는 상위 4개 소재 주식</a></li>
</ul>
사진 제공: Pixabay

목요일 오전 (현지 시간 기준) 미국 주식 선물 거래가 혼조세를 보이고 있는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다:
<ul>
<li>월스트리트는 일라이 릴리 앤드 컴퍼니 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)가 개장 전 매출 99억 5천만 달러, 주당 2.70달러의 분기 이익을 보고할 것으로 예상한다. 일라이 릴리의 주가는 시간외 거래에서 0.9% 하락한 765.32달러를 기록했다.</li>
<li></li>
<li>블루 버드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>)는 예상보다 나은 3분기 재무 실적을 보고하고 새 CEO를 발표했다. 블루버드 주가는 시간외 거래에서 5.3% 상승한 51.00달러를 기록했다.</li>
<li></li>
<li>분석가들은 US 푸즈 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)이 96억 4천만 달러의 매출과 주당 93센트의 분기 이익을 발표할 것으로 예상하고 있다. 회사는 시장이 열리기 전에 실적을 발표할 예정이다. US 푸즈의 주가는 시간외 거래에서 0.2% 상승한 51.20달러를 기록했다.</li>
<li></li>
<li>아웃셋 메디컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>)는 예상보다 나쁜 2분기 재무 결과를 보고하고 FY24 매출 지침을 하향 조정했다. 아웃셋 메디컬의 주가는 시간외 거래에서 39.7% 하락한 2.05달러를 기록했다.</li>
<li></li>
<li>분석가들은 파커 하니핀(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>)이 개장 전 매출 50억 8천만 달러, 주당 6.22달러의 분기 이익을 발표할 것으로 예상한다. 파커 하니핀의 주가는 수요일 1.1% 하락한 512.50달러로 마감했다.</li>
<li></li>
</ul>
Photo courtesy: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

BLBD

목요일 주목해야 할 주식: 일라이 릴리, US 푸즈, 블루 버드 그리고 종목

목요일 아침 (현지 시간) 미국 주식 선물이 하락세로 거래되면서 오늘 투자자의 관심을 끌 수 있는 주식은 다음과 같다:
<ul>
<li>월스트리트는 로블록스 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)가 개장 전 주당 53센트의 분기 손실과 9억 2,200만 달러의 매출을 보고할 것으로 예상하고 있다. 로블록스의 주식은 시간외 거래에서 0.7% 상승한 39.30달러를 기록했다.</li>
<li>줌인포 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NYSE">ZI</a>)는 긍정적인 1분기 실적을 발표했지만, 2분기 전망은 예상보다 약했다. 이 회사는 2분기 EPS가 주당 25센트 추정치보다 23센트~24센트 범위에 있을 것으로 예상하고 있다. 2분기 매출은 추정치 3억 1,311만 달러 대비 3억 600만~3억 900만 달러로 예상된다. 줌인포의 주식은 시간외 거래에서 0.4% 상승한 12.19달러에 거래되었다</li>
<li>애널리스트들은 US 푸즈 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>)가 분기당 주당 53센트의 이익과 89억 2,000만 달러의 매출을 발표할 것으로 예상하고 있다. 이 회사는 개장 전에 분기 실적을 발표할 것이다. US 푸즈의 주식은 시간외 거래에서 1.4% 상승한 53.10달러에 거래됐다.</li>
</ul>
이곳에서 <a href="https://www.benzinga.com/premarket/">개장 전 시황 개요를 확인하세요</a>
<ul>
<li>비욘드 미트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>)가 1분기에 예상보다 큰 손실을 기록했다. 이 회사는 2분기 매출이 8,500만 달러에서 9,000만 달러 사이일 것으로 예상하고 있으며, 2024년의 전체 매출은 3억 1,500만 달러에서 3억 4,500만 달러 사이로 예상하고 있다. 비욘드 미트의 주식은 시간외 거래에서 13.5% 하락한 7.10달러에 거래되었다.</li>
<li>애널리스트들은 H&amp;R 블록(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRB#NYSE">HRB</a>)가 시장 마감 후 주당 4.62달러의 분기 이익과 214억 달러의 분기 매출을 발표할 것으로 예상하고 있다. H&amp;R 블록의 주식은 시간외 거래에서 0.9% 상승한 48.95달러에 거래됐다.</li>
</ul>

Comments

US Foods Hldg

뉴스

에 대한 최신 뉴스 US Foods Hldg (NYSE:USFD) 주식

목요일, 2월 06, 2025

금요일, 10월 25, 2024

월요일, 9월 30, 2024

목요일, 8월 08, 2024

목요일, 5월 09, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌